Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-22-053989

Chief Financial Officer gave up 1,111 shares (to pay taxes)

  • Chief Financial Officer acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Brendan Chief Financial Officer 2022-10-14 Option exercise +3,750 3,750 D
Smith Brendan Chief Financial Officer 2022-10-17 Shares withheld for taxes −1,111 $55.76 $61,949 2,639 D
Derivatives
Smith Brendan Chief Financial Officer 2022-10-14 Option exercise · Restricted Stock Units +3,750 11,250 D
Loading xslF345X03/doc4.xml…